DOYU
Q4 2026 EPS Estimate
$0.01
Nov 25, 2026 · Reports before open
Revenue Estimate
$125M
FY2026E EPS$0.10
FY2027E EPS$2.14

Analyst Sentiment

Wall St. Consensus
Hold
7 analysts·Limited coverage
54
Score
1 Buy (14%)6 Hold (86%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
114%
Hold
686%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$5.50
+27.0%
Consensus
$6.60
+52.4%
Bull
$15.00
+246.4%
12-Month Target Range7 analysts
$5.50$6.60$15.00
Current $4.33Consensus
Current Price
$4.33
Upside to Consensus
$2.27

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev-2.71%
EPS+2052.98%
FY2028
Rev-0.65%
EPS+37.93%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026EFY2027EFY2028E
Revenue Avg$3.66B$3.56B$3.54B
Low$3.61B$3.50B$3.41B
High$3.72B$3.63B$3.67B
EBITDA Avg$32M$107M$136M
Low$32M$103M$133M
High$32M$111M$139M
EBIT Avg$4M$82M$113M
Low$4M$78M$110M
High$4M$85M$116M
Net Income Avg$3M$64M$89M
Low$3M$62M$87M
High$3M$67M$91M
EPS Avg$0.10$2.14$2.95
Low$0.10$2.04$2.87
High$0.10$2.23$3.02
Analysts (Rev / EPS)2 / 12 / 12 / 1
Quarterly
MetricQ3 2026Q4 2026
Revenue Avg$853M$936M
Low$853M$936M
High$853M$936M
EBITDA Avg$16M$36M
Low$16M$36M
High$16M$36M
EBIT Avg$3M$23M
Low$3M$23M
High$3M$23M
Net Income Avg$2M$18M
Low$2M$18M
High$2M$18M
EPS Avg$0.08$0.59
Low$0.08$0.59
High$0.08$0.59
Analysts (Rev / EPS)1 / 11 / 1

Earnings Surprises

Recent Analyst Actions

Sep 16, 2024Citigroup
DouYu (DOYU) PT Raised to $5.50 at Citi
Target:$5.50
-29.4%from $7.79
Jul 3, 2024HSBC
DouYu upgraded to Hold from Reduce at HSBC
Target:$15.00
-16.4%from $17.94
Apr 1, 2024Morgan Stanley
DouYu (DOYU) PT Lowered to $6.60 at Morgan Stanley, 'No Turnaround Yet'
Target:$6.60
+0.2%from $6.59
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.